08/11/2025
3:29 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form 424B3 | |
07/17/2025
7:12 PM | BlackRock, Inc. (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/01/2025
8:21 PM | Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Sandler Laura Lee (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/01/2025
8:26 PM | Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Sandler Laura Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
3:30 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest III L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
7:00 AM | Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G | |
03/11/2025
11:15 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form EFFECT | |
03/10/2025
6:00 PM | Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
03/06/2025
4:17 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form POS AM | |
02/27/2025
5:42 PM | Koh Bong Y (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/27/2025
5:42 PM | Koh Bong Y (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ORKA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oruka Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/27/2025
5:43 PM | Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/05/2025
3:00 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
3:44 PM | Agarwal Arjun (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:41 PM | Klein Lawrence Otto (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:42 PM | Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Quinlan Paul T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:43 PM | Goncalves Joana (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
6:16 AM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
11:15 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form EFFECT | |
11/21/2024
5:30 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
5:30 PM | Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
| Form SC 13D/A | |
11/14/2024
6:38 PM | Avidity Partners Management LP (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
4:49 PM | Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:20 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/14/2024
3:56 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
11:04 AM | Allostery Investments LP (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
8:56 AM | JANUS HENDERSON GROUP PLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
5:37 AM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/13/2024
3:01 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/22/2024
3:15 PM | Adage Capital Management, L.P. (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
| Form SC 13D/A | |
10/18/2024
3:11 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form DEF 14A | |
10/07/2024
10:37 AM | FMR LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
| Form SC 13G | |
10/04/2024
3:05 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:55 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:57 PM | Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
| Form SC 13D/A | |
09/06/2024
4:00 PM | Klein Lawrence Otto (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2024
4:01 PM | Agarwal Arjun (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2024
4:02 PM | Goncalves Joana (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2024
4:03 PM | Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Quinlan Paul T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2024
4:04 PM | BALL KRISTINE M (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2024
4:05 PM | Dambkowski Carl (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
How “Trump’s New Dollar” Could Impact Your Wealth (Ad) President Trump just signed a game-changing law…
That could soon upgrade the U.S. dollar in your checking and savings account…
With this better, more technologically advanced dollar.
President Trump himself called it a "big innovation"…
And said that this new form of currency represents "American brilliance at its best." Click here now because Chase, Bank of America, Citigroup, Wells Fargo, and U.S. Bancorp… |
09/06/2024
4:06 PM | Kulkarni Samarth (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2024
4:07 PM | Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Turtle Cameron (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2024
4:07 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest III L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2024
4:08 PM | Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
| Form SC 13D | |
09/05/2024
4:18 PM | Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
